Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-17

Clinical Trial Update: Epi-Genetic Modulators of Fear Extinction in Alcohol Dependence

View source ↗

Summary

This clinical trial examined epigenetic modulators of fear extinction in individuals with alcohol use disorder. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Fear, Stress | Status: COMPLETED